Oxiteston 50 mg Sopharma

Description

Oxiteston 50 mg Sopharma — No other oral anabolic steroid matches the sheer mass-building velocity of Oxymetholone. Its dramatic effects on muscle glycogen supercompensation, nitrogen retention, and red blood cell production create the rapid, visible size and strength increases that define the compound. This formulation is dosed at 50 mg per unit.

Key Benefits

• Highest anabolic:androgenic ratio of any common AAS (~322–630 / 24)
• Does NOT aromatise — zero oestrogenic side-effects
• Minimally hepatotoxic relative to other 17α-alkylated orals
• Mitochondrial fatty-acid uptake enhancement — cutting utility
• One of few AAS with documented female protocols (5–20 mg/day)
• Each unit dosed at 50 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: men 20–80 mg/day split two or three times daily; women 5–20 mg/day single dose. Standard cycle 6–8 weeks. Above 80 mg/day gains plateau while liver-enzyme burden continues rising.

How It Works

17α-alkylated DHT-derivative with a modified A-ring that strips androgenic expression while keeping anabolic activity. Does not aromatise. Binds the androgen receptor with modest affinity; results come from elevated protein synthesis, mitochondrial fatty-acid uptake, and erythropoiesis rather than raw AR occupation.

Pharmacokinetics

Oral bioavailability ~97% — highest of any AAS. Plasma half-life approximately 9 hours; splitting the daily dose across 2–3 administrations keeps serum levels flat. Hepatotoxicity low relative to methylated orals but still real; pull ALT/AST at week 4.

Potential Side Effects

Lipid panel disruption (HDL drop) is consistent. Mild LH/FSH suppression even at low doses — mini-PCT appropriate after 6+ week cycles. No water retention, no oestrogenic effects. Androgenic sides (hair-thinning in susceptible users) possible at higher doses.

Cycle & Stacking Guide

Cutting adjunct on a testosterone base, 6–8 weeks. Stacks with test + masteron for pre-contest hardening or with clen + T3 for recomp. Often used as a finisher (final 6 weeks of a 14-week cycle). TUDCA 500 mg/day throughout.

Manufacturer Notes

Sopharma is a Bulgarian pharmaceutical producer with over 80 years of history. Their products are GMP-compliant and dispensed through European pharmacy channels.

Storage & Handling

Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.